今天是:   返回主页   |   加入收藏   |   联系我们
引用本文:
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  下载PDF阅读器  关闭
附件
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1741次   下载 2089 本文二维码信息
码上扫一扫!
分享到: 微信 更多
马连珍主任以定痛救心胶囊治疗冠心病经验
贾俊兵, 樊瑞红
天津市中医药研究院附属医院心内科, 天津 300120
摘要:
冠心病是心血管系统的常见病、多发病,马连珍主任医师,经过40余载研究,认为阳虚寒凝,脉络瘀阻是冠心病心绞痛常见证型,并研制出定痛救心胶囊,研究显示具有抗动脉粥样硬化、抗血小板聚集、降血脂、改善血液流变性、抑制自由基的产生,抑制炎症细胞因子的释放等作用,符合现代医学冠心病的发病机制,为该方用于冠心病治疗提供了科学依据,值得临床推广。
关键词:  马连珍  胸痹  冠心病心绞痛
DOI:10.11656/j.issn.1672-1519.2016.02.01
分类号:
基金项目:马连珍学术思想研究室资助项目。
Experience of Director MA Lian-zhen in the treatment of coronary heart disease by Dingtong Jiuxin capsules
JIA Jun-bing, FAN Rui-hong
Department of Cardiology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin 300120, China
Abstract:
Coronary heart disease is a common disease of cardiovascular system. MA Lian-zhen director, after more than 40 years of research, believed that Yang deficiency cold coagulation, blood stasis resistance was a common syndrome type, and developed the Dingtong Jiuxin capsules which had the effect of anti atherosclerosis, anti-platelet aggregation, lowering blood lipids, improving blood rheology, inhibiting the release of inflammatory cytokines, to provide the scientific basis for the treatment of coronary heart disease, and it was worthy of clinical promotion.
Key words:  MA Lian-zhen  thoracic obstruction  angina pectoris of coronary heart disease
关注公众号二维码